Cargando…
From conventional therapy toward microRNA-based therapy in acute promyelocytic leukemia
Acute promyelocytic leukemia (APL) is a hematopoietic malignancy that is known with its special cytogenetic feature. Several studies have surveyed expression signature of microRNAs (miRNAs) in APL patients, especially patients who are treated with conventional therapy of this disease. Using miRNAs a...
Autores principales: | Ehtesham, Naeim, Sharifi, Mohammadreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156975/ https://www.ncbi.nlm.nih.gov/pubmed/28028527 http://dx.doi.org/10.4103/2277-9175.190996 |
Ejemplares similares
-
Inhibition of microRNA miR-92a induces apoptosis and necrosis in human acute promyelocytic leukemia
por: Sharifi, Mohammadreza, et al.
Publicado: (2014) -
WITHDRAWN: Inhibition of MicroRNA miR-92a Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia: This article has been withdrawn due to the fact that it is published in three different journals.
por: Sharifi, Mohammadreza, et al.
Publicado: (2013) -
HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia
por: Vitkevičienė, Aida, et al.
Publicado: (2019) -
Therapy-Related Acute Promyelocytic Leukemia Developed During Pembrolizumab Therapy
por: Ober, Cecily E, et al.
Publicado: (2023) -
Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia
por: Zhang, Hua, et al.
Publicado: (2011)